Navigation Links
American Oriental Bioengineering Announces September Investor Conferences Participation
Date:9/8/2009

NEW YORK, Sept. 8 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced the Company's participation in the following conferences:

    -- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009
       in Boston, MA.  Management will meet with institutional investors
       throughout the day.

    -- Morgan Stanley Global Healthcare Unplugged Conference, to be held
       September 14-15, 2009 in New York City. Management will meet with
       institutional investors throughout both days.

    -- Merrill Lynch/Bank of America Global Drug, Biotech & Medical Devices
       Conference, to be held September 15-17, 2009 in London. Management will
       present at 1:45pm London Time on September 16, 2009 and meet with
       institutional investors throughout all three days. A live webcast of
       the presentation will be available via the Company's website at
      http://www.bioaobo.com/ .

    -- Susquehanna Financial Group Third Annual Beijing Management Summit, to
       be held September 16-17, 2009 in Beijing, China. Management will speak
       on a panel discussion entitled, "China Pharma/Biotech Panel
       Participants," scheduled from 1:05-2:10pm Beijing Time on September 16,
       2009. In addition, management will also present at 9:45am Beijing Time
       on September 16, 2009 and meet with institutional investors throughout
       both days.

For further details, please contact your respective institutional sales
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
2. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
3. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
4. American Oriental Bioengineering Announces Change in Independent Auditor
5. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
6. American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
7. American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
8. American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China
9. American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
10. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
11. New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...
(Date:12/14/2009)... -- Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") ... with The Scripps Research Institute ("Scripps") by entering ... genome of Dyadic,s patented and proprietary C1 fungus ... the successful relationship between the two organizations which ... to annotate the C1 genome for the first ...
(Date:12/14/2009)... CARLOS, Calif., Dec. 14 Nektar Therapeutics ... Winger has been appointed to serve on its ... biopharmaceutical industry leader with over 35 years of ... ,, "Dennis brings to Nektar extensive industry perspective ... said Howard W. Robin, President and CEO of ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... not today. May 1 is International Workers' Day , ... society and economy of the working class. Throughout the U.S. ... streets in support of a more practical and fair immigration ... to keep their wallets in their pockets to demonstrate the ...
... Responding to cumbersome production processes for radioisotopes, NorthStar ... with PG Research Foundation of Darien, Ill., ... promise of expediting the delivery of radioisotopes used in ... Janesville with offices in Madison and Naperville, Ill., develops ...
... of Wisconsin-Madison researchers have until June 1 to ... designed to stimulate collaborative research projects. , ,The ... provide $3 million in private funding to encourage collaborative ... in advance of the institutes' opening in late 2009. ...
Other Biology Technology:Technology and the "American" dream 2NorthStar signs exclusive agreement with Illinois foundation 2UW-Madison sets June 1 deadline for research proposals 2
(Date:12/15/2009)... 2006, a team of Spanish and American researchers found the ... Bonares, Huelva. Now they have published, for the first time, ... with the death of the young cetacean, possibly a baleen ... first discovery of the partial fossil remains of a whale ... Huelva Sands sedimentary formation, but it is the first time ...
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
(Date:12/15/2009)... The mouse is a standard laboratory model organism, ... conventional techniques to analyze blood and blood-forming tissues ... of compact and easy-to-use laboratory resources from Cold ... Mouse Hematology features step-by-step protocols for ... blood, bone marrow, and other hematopoietic tissues in ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3New source of classical techniques for blood-based studies in the laboratory mouse 2Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit 56363 1Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit 56363 2Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit 56363 3Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit 56363 41 200 RNs Gather in San Francisco Tuesday 3A Take Next Step to Form Nations Largest Ever Union of Nurses 56360 11 200 RNs Gather in San Francisco Tuesday 3A Take Next Step to Form Nations Largest Ever Union of Nurses 56360 2Multiple Abstracts Related to KRYSTEXXA 28TM 29 Development and Treatment Failure Gout to be Presented at the 2009 ACR ARHP Annual Scientific Meeting 13887 1Multiple Abstracts Related to KRYSTEXXA 28TM 29 Development and Treatment Failure Gout to be Presented at the 2009 ACR ARHP Annual Scientific Meeting 13887 2Multiple Abstracts Related to KRYSTEXXA 28TM 29 Development and Treatment Failure Gout to be Presented at the 2009 ACR ARHP Annual Scientific Meeting 13887 3Multiple Abstracts Related to KRYSTEXXA 28TM 29 Development and Treatment Failure Gout to be Presented at the 2009 ACR ARHP Annual Scientific Meeting 13887 4
... year to the UK poultry industry but scientists are now ... ?one that can be delivered while they are still in ... provides immunity to IBV has been developed by scientists at ... UK. It can be delivered to chicks still in the ...
... bat that has large flat adhesive organs, or suckers, attached ... find because the new bat belongs to a Family of ... include only one rare species. , The new species, ... Madagascar, while the previously known species, Myzopoda aurita, occurs only ...
... creepy-crawly, are giving new meaning to the term touchy-feely. ... amblypygids, mothers caress their young with long feelers, siblings ... mix in social groups. This is surprising behavior for ... according to a Cornell researcher. , Social behavior ...
Other Biology News:In-shell vaccine for chick disease 2New sucker-footed bat discovered in Madagascar 2A rarity among arachnids, whip spiders have a sociable family life 2A rarity among arachnids, whip spiders have a sociable family life 3
Mouse anti-JNK (PT183/185) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Acetyl CoA Carboxylase Antibody...
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
Biology Products: